No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin

被引：0
|
作者：
Singhal, MK [1 ]
Bhaskaran, S [1 ]
Szabo, T [1 ]
La Rosa, R [1 ]
机构：
[1] Toronto Hosp, Western Div, Div Nephrol, Peritoneal Dialysis Unit, Toronto, ON M5T 2S8, Canada
来源：
PERITONEAL DIALYSIS INTERNATIONAL | 1999年 / 19卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89 / 91
页数：3
相关论文
共 50 条
  • [31] Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir
    De Requena, DG
    Blanco, F
    Garcia-Benayas, T
    Jiménez-Nácher, I
    González-Lahoz, J
    Soriano, V
    AIDS PATIENT CARE AND STDS, 2003, 17 (09) : 443 - 445
  • [32] Effect of statins on plasma fibrinogen levels in hypertensive hyperlipidemic patients
    Nalbantgil, S
    Nalbantgil, I
    Boydak, B
    Ozerkan, F
    Gurgun, C
    Zoghi, M
    Aytimur, M
    Onder, R
    JOURNAL OF HYPERTENSION, 2002, 20 : S316 - S316
  • [33] Plasma fibrinogen levels in patients with benign and malignant ovarian tumors
    Hefler-Frischmuth, Katrin
    Lafleur, Judith
    Hefler, Lukas
    Polterauer, Stephan
    Seebacher, Veronika
    Reinthaller, Alexander
    Grimm, Christoph
    GYNECOLOGIC ONCOLOGY, 2015, 136 (03) : 567 - 570
  • [34] Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia
    Branchi, A
    Fiorenza, AM
    Torri, A
    Muzio, F
    Berra, C
    Colombo, E
    Dalla Valle, E
    Rovellini, A
    Sommariva, D
    CLINICAL THERAPEUTICS, 2001, 23 (06) : 851 - 857
  • [35] LDL Cholesterol Variability in Patients with Type 2 Diabetes Taking Atorvastatin Compared to Simvastatin: A New Aspect to Lipid Lowering?
    Sathyapalan, Thozhukat
    Atkin, Stephen L.
    Kilpatrick, Eric S.
    DIABETES, 2009, 58 : A246 - A246
  • [36] Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
    Andrey Sivkov
    Natalya Chernus
    Roman Gorenkov
    Sergey Sivkov
    Svetlana Sivkova
    Tamara Savina
    Lipids in Health and Disease, 20
  • [37] Relationship between genetic polymorphism of drug transporters and the efficacy of Rosuvastatin, atorvastatin and simvastatin in patients with hyperlipidemia
    Sivkov, Andrey
    Chernus, Natalya
    Gorenkov, Roman
    Sivkov, Sergey
    Sivkova, Svetlana
    Savina, Tamara
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)
  • [38] The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer's Disease
    Fan, Dong-Yu
    Sun, Hao-Lun
    Sun, Pu-Yang
    Jian, Jie-Ming
    Li, Wei-Wei
    Shen, Ying-Ying
    Zeng, Fan
    Wang, Yan-Jiang
    Bu, Xian-Le
    FRONTIERS IN NEUROSCIENCE, 2021, 14
  • [39] Association between fibrinogen plasma levels and platelet counts in an outpatient population and in patients with coronary heart disease
    Aliberti, Giuseppe
    Proietta, Maria
    Pulignano, Isabella
    Del Porto, Flavia
    Tammeo, Andrea
    Trappolini, Massimo
    BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (03) : 216 - 220
  • [40] Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study
    Kaya, Cemil
    Cengiz, Sevim Dincer
    Berket, Buelent
    Demirtas, Selda
    Cesur, Mustafa
    Erdogan, Guerbuez
    FERTILITY AND STERILITY, 2009, 92 (02) : 635 - 642
12345